When medicine turns poison: The unending tragedy of contaminated cough syrups

There is something deeply unsettling when a bottle meant to cure a child’s cough becomes the reason for a child’s death.

Recent reports from various parts of the world, including India, have again raised alarms about contaminated cough syrups that caused fatalities among children.

Such tragedies expose not only the fragility of our drug regulation system but also the complacency that creeps into public health vigilance.

Cough syrups are among the most commonly used over-the-counter medicines—administered across all ages, genders, and socioeconomic classes.

That something as routine as a spoonful of syrup can turn lethal is a grim reminder that medicine, without accountability, can easily become poison.

The recurring nature of these incidents reflects systemic failures rather than isolated mishaps.

Whenever a crisis erupts, statements are issued, licenses suspended, and enquiries announced, but once the news fades, the same lax practices return.

The tragedy linked to contaminated syrups is not new—similar episodes have been reported from Gambia, Uzbekistan, and even within Indian states.

What binds these events is the use of substandard ingredients, unchecked excipients like diethylene glycol, and the failure of basic quality control.

It raises a haunting question: if a five-rupee syrup bottle can slip through regulatory cracks, how safe are the other thousands of formulations we consume daily?

Equally disturbing are reports of expired saline solutions or mislabelled drugs being administered to patients in hospitals.

These errors are not just moral or procedural lapses—they are preventable tragedies. They call for an honest assessment of how medicines move from manufacturer to bedside, and where our vigilance collapses.

The pharmaceutical industry in India is among the largest in the world, exporting to over 150 countries.

Yet, within our borders, monitoring remains patchy. Regulatory labs are underfunded, pharmacists are overworked, and hospital supply chains are vulnerable to shortcuts and neglect.

The 6 Rs of Dispensing and Prescribing Medicines; The safe use of medicines depends on accuracy and accountability.

To minimise medication errors, healthcare professionals follow the “6 Rs” — six essential checks that safeguard both patients and prescribers.

Right Patient: Always confirm the patient’s identity through name, age, and medical record to prevent giving a drug to the wrong person.

Right Medicine: Ensure the prescribed drug matches the patient’s diagnosis and treatment plan.

Misreading names (e.g., similar-sounding drugs) can be fatal.

Right Dose: Verify the correct dosage according to age, weight, and condition.

Both underdosing and overdosing can harm patients.

Right Route: Administer through the correct route—oral, intravenous, intramuscular, or topical—as per prescription.

Right Time: Give medication at the right intervals to maintain therapeutic levels and prevent resistance or toxicity.

Right date: check the date of expiry.

Right Documentation (or Record): Record every drug administered or dispensed to ensure accountability and traceability.

Documentation includes checking bills, the right price, and the right quantity dispensed before leaving the pharmacy counter

Together, these 6 Rs form the foundation of rational prescribing and safe dispensing practices—turning medicine from a potential hazard into healing.

Medication errors—whether in prescribing, dispensing, or administering—form one of the leading causes of preventable harm in healthcare.

In a system already struggling with workforce shortages and bureaucratic inertia, such errors are often dismissed as “unfortunate accidents.”

But every error has a root cause: a missed step in verification, a wrong label, a poor checklist, or an assumption that someone else must have checked it.

To reduce these errors, hospitals and pharmacies must adopt what patient safety experts call the “Swiss cheese model.”

In this model, every layer—prescribing, preparing, labelling, dispensing, administering—acts as a slice of defence.

Even if one layer fails, another catches the error before harm occurs. When all slices align—when every weakness lines up—the error slips through, and tragedy strikes.

Unfortunately, our healthcare system often lacks even these multiple slices.

The pharmacist is rarely involved in clinical decision-making. The nurse administering a drug may be overburdened and fatigued.

The physician may prescribe based on outdated brand names without checking the composition or expiry.

What should be a chain of safety checks becomes a line of assumptions.

Introducing electronic prescribing systems, barcode-based dispensing, and digital audits can significantly reduce the margin for human error. But beyond technology, what is required is a culture of safety—where every healthcare worker feels responsible for patient wellbeing and empowered to question irregularities.

The responsibility does not rest only with professionals. Consumers, too, must be vigilant.

Many families stock up on syrups and pills at home without checking manufacturing or expiry dates.

Some buy antibiotics over the counter without prescriptions, fuelling both resistance and risk.

Education campaigns must remind citizens that self-medication, however convenient, is not harmless.

Parents should be trained to read labels, avoid multiple syrups for the same symptom, and never use leftover medicines.

The habit of consulting a pharmacist or doctor before giving a child any medication must become as natural as checking the expiry date on food.

Regulatory authorities, on their part, must strengthen post-market surveillance. Random sampling of drug batches, surprise inspections, and strict penalties for violations can deter negligence.

But what we need most is transparency—public disclosure of inspection reports, blacklisted manufacturers, and test results.

When citizens know which companies have failed standards, market trust shifts toward safer brands. Transparency is the strongest disinfectant against corruption and complacency.

The tragic irony is that the same nation capable of producing world-class vaccines and lifesaving generics often fails to protect its own citizens from adulterated basics.

This is not a technological problem but an ethical one. Every contaminated syrup represents a broken trust between doctor, manufacturer, and society.

When a child’s medicine becomes her poison, we have not just failed as regulators or clinicians—we have failed as a civilisation that promised to protect its weakest.

As we debate medical advances, healthcare budgets, and new hospitals, we must also look inward. Patient safety begins not in the ICU or the operating theatre, but in the factory floor, the storage shelf, and the pharmacy counter.

It begins with a checklist, a conscience, and a commitment that no child’s life should end because someone ignored a small detail. The next time we reach for a bottle of cough syrup, may we remember that behind its label lies a chain of accountability—and that chain must never be allowed to break.

The author is a Senior Consultant Surgeon, clinical auditor, and healthcare policy expert committed to enhancing quality and safety standards in Jammu and Kashmir. He can be reached at drfiazfazili@gmail.com